Since its discovery in 1952, much has been learned concerning the thyroxine (T4)-binding globulin of human plasma (TBG) [cf. Reviews (1, 2)]. Although its concentration in plasma has not been directly measured and is presumably very low, the capacity of TBG to bind T4 is readily measured and is normally about 20 ug per 100 ml of serum or plasma (1) . Recently, several patients have been described in whom the T4-binding capacity of TBG is either greatly increased or decreased, apparently on a hereditary basis (3) (4) (5) (6) (7) (8) . Physiological studies in such patients have contributed much to a formulation of the role of this protein in the peripheral metabolism of T4 (3, 5, 7, 8) . On the other hand, little has been done to elucidate either the cause of the protein abnormality itself or the presence of associated abnormalities in other plasma transport proteins.
The availability of a patient with an apparently idiopathic increase in the T4-binding capacity of TBG has made possible further studies of this disorder. Since ceruloplasmin [cf. Review (9) ] and the corticosteroid-binding globulin (transcortin) (10) (11) (12) (13) (14) , like TBG (15) (16) (17) , normally increase in concentration or binding activity in re-* Submitted for publication June In June 1961, an increase in the binding activity of TBG was considered as the possible cause of her abnormal PBI. Electrophoretic studies of her serum revealed the T4-binding activity of TBG to be greatly increased. In view of the persistently normal values for BMR and thyroidal I131 uptake, both before and after I'31 therapy, and the normal thyroid suppression test, it would appear likely that the patient's persistently increased PBI was never due to thyrotoxicosis, but was, instead, a consequence of increased hormonal binding in the plasma.
In August 1962, the patient was admitted to the Strong Memorial Hospital to receive a 3-week course of diethylstilbestrol, 30 mg daily. The control cervical smear revealed no evidence of estrogenic effect. A progressive effect was noted during treatment, however, and was marked by the time diethylstilbestrol was discontinued. Withdrawal vaginal bleeding followed a few days thereafter.
The patient was readmitted in November 1962 to receive a 3-week course of norethandrolone, 50 mg daily. During the treatment period, serum glutamic-oxalacetic transaminase values increased from 20 to 60 U. Serum bilirubin upon completion of therapy was 1 mg per 100 ml. Balance studies performed during and after the treatment period revealed that norethandrolone induced significant nitrogen retention.
In July of 1963, the patient was readmitted for a second course of diethylstilbestrol treatment in order to verify the previously observed findings with regard to the effects of this agent on T4-binding and to assess its effects on other plasma transport proteins.
Procedure. Thyroxine-binding capacities of TBG and thyroxine-binding prealbumin (TBPA) in serum were measured by methods described in detail earlier, employing paper electrophoresis in Tris-maleate buffer, pH 8.6 (7) . Concomitantly, the distribution of tracer quantities of P`31-labeled thyroxine, reflecting the binding of the endogenous hormone, was also assessed. Analyses for the proportion of unbound T4 in serum were carried out by an equilibrium dialysis technique, recently described in abstract form (18) , to be described in detail in a later communication. Serum PBI was measured by a modification of the method of Zak (19) . Plasma 17-OH corticosteroids were analyzed by the method of Peterson, Karrer, and Guerra (20) , and transcortin concentrations by the method of Daughaday, Adler, Mariz, and Rasinski (14) . Ceruloplasmin was measured by the method of Scheinberg and Morell (21) . Serum iron-binding capacities were measured by the method of Peters, Biovanniello, Apt, and Ross (22) . Response to diethylstilbestrol. During two separate 3-week trials of diethylstilbestrol, no significant change in the PBI, in the proportion of unbound T4, or in the concentration of free T4-iodine in the serum occurred. The T4-binding capacity of TBG showed little, if any, response to estrogen administration. During the first trial, the binding capacity was 52 ug per 100 ml in the basal state and 63 per 100 ml after 3 weeks of therapy. During the second trial, comparable values were 56 and 60 Mg per 100 ml, respectively.
The per cent of endogenous T4 bound by TBG increased slightly and that bound by TBPA decreased.
In contrast to these negligible changes in the binding of thyroxine, pronounced increases in the concentration of cortisol, transcortin, and ceruloplasmin occurred during administration of estrogen. Total serum iron-binding capacity and serum iron were not significantly affected.
Response to anabolic steroid. In contrast to the relative lack of change in T4-binding that occurred during administration of diethylstilbestrol, pronounced changes in T4-binding occurred during administration of norethandrolone. The thyroxine-binding capacity of TBG decreased to normal, the PBI to the lower limit of the normal range. Concomitantly, the proportion of unbound thyroxine increased to values slightly in excess of normal, with the result that the concentration of free thyroxine iodine remained essentially unchanged. The T4-binding capacity of TBPA increased from its low basal value, but did not come into the normal range. In the present patient, the T4-binding capacity of TBG, the PBI, and the per cent of free T4 in the serum were all within the range to be expected either during normal pregnancy or in response to large quantities of estrogen (15) (16) (17) . Neither of these explanations of the abnormality was tenable, however, since the patient was postmenopausal and the cervical smear revealed no evidence of estrogenic effect. Thus, her disorder appears to merit the designation "idiopathic increase in TBG."
Although the patient's increased TBG could not be ascribed to estrogen, evidence was obtained that both genital and extragenital effects of estrogen could be elicited. Intense estrogenic effect on the cervix and vaginal bleeding followed administration and withdrawal, respectively, of diethylstilbestrol. In addition, this agent evoked an increase in the concentrations of transcortin and ceruloplasmin in the plasma, a response similar to that seen in normal individuals (9) (10) (11) (12) (13) (14) . Although the patient responded to estrogen in these respects, the patient's already increased TBG was unaffected by diethylstilbestrol in a dosage and duration that normally increase TBG greatly. Doses of anabolic steroid, sufficient to induce nitrogen retention, in contrast, lowered the TBG and PBI and increased the proportion of free T4 in the serum, a response similar to that elicited in normal subjects (23) .
From these and other findings it is possible to draw several inferences concerning the nature of the underlying disorder in patients with idiopathic increase in TBG, at least to the extent to which this patient may be typical of others. It From the present studies it is additionally apparent that the abnormality in protein metabolism, evident in the increased TBG, was not general to other proteins whose concentrations in the plasma are normally increased by estrogens. Concentrations of ceruloplasmin and transcortin were normal in the basal state and, as might therefore be expected, demonstrated a normal increase in response to estrogen therapy.
In view of the existing data concerning transferrin, studies of this protein in the patient's serum were inconclusive. Concentrations of transferrin are usually increased during normal pregnancy, but there is considerable overlap between values usually found in pregnancy and the rather broad normal range [cf. Review (24)]. Furthermore, it is not certain whether the increase in the concentration of transferrin that occurs during pregnancy is due to a relative iron deficiency or whether transferrin is estrogen-responsive, like TBG, transcortin, and ceruloplasmin. Values for the total iron-binding capacity of the present patient's serum were at the upper limit of normal, and although no increase was elicited by diethylstilbestrol, it is not known whether this would normally be expected.
Finally, the present studies provide further evi-dence of the physiological consequences of T4-binding. It is generally agreed that although the proportion of free T4 may vary in diverse states, the physiologically important variable is the concentration of free T4 in the plasma. In the present patient, despite a substantial increase in the total hormonal concentration, the proportion of free hormone, not heretofore measured in this syndrome, was decreased. As a result, the concentration of free T4-iodine was normal, and this was associated with a normal metabolic state and normal thyroid function. When, on the other hand, the binding of T4 was decreased by norethandrolone and the proportion of free hormone increased, the hormonal concentration in the blood declined until the free T4-iodine was within the normal range and the patient remained metabolically normal. These findings strengthen further the now well-supported hypothesis that both the homeostatic mechanisms which regulate thyroid function and the metabolic state of the patient are conditioned by the concentration in plasma of free or unbound, rather than total, T4 (1, 2). Summary Studies have been performed in a 66-year-old, postmenopausal female whose serum proteinbound iodine (PBI) was abnormally high despite normal thyroid function and a normal basal metabolic rate. Electrophoretic analyses indicated that' the increased PBI was associated with an idiopathic increase in the binding activity of the plasma thyroxine (T4)-binding globulin (TBG). Although the T4-binding capacity of TBG was in the range usually observed in pregnant patients or those receiving large doses of estrogen, no evidence of endogenous excess of estrogen could be obtained. In the basal state, the increased TBG was associated with an increased PBI and a decreased proportion, but normal concentration, of free T4 in the serum. During two separate trials of diethylstilbestrol daily for 3 weeks, none of these functions, including the TBG, changed significantly. During administration of norethandrolone, in contrast, TBG and PBI decreased, the proportion of free T4 increased, but the concentration of free T4-iodine remained normal.
In contrast to the findings with regard to TBG, concentrations of ceruloplasmin and transcortin in the serum were normal in the basal state and increased normally during administration of estrogen.
It is concluded that in this patient, at least, the increase in TBG is not associated with abnormalities in other estrogen-sensitive transport proteins and may be due to an estrogen-independent activation of the same mechanism by which estrogen normally increases TBG.
